Role of 2′,3′-cyclic nucleotide 3′-phosphodiesterase in the renal 2′,3′-cAMP-adenosine pathway

American Journal of Physiology - Renal Physiology

Volumn 307, Issue 1, 2014, Pages

  Jackson, Edwin K ^a   Gillespie, Delbert G ^a   Mi, Zaichuan ^a   Cheng, Dongmei ^a   Bansal, Rashmi ^b   Janesko Feldman, Keri ^a,c   Kochanek, Patrick M ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

2 ,3 cyclic adenosine monophosphate; 2 ,3 cyclic nucleotide 3 phosphodiesterase; 2 adenosine monophosphate; 3 adenosine monophosphate; Adenosine; CNPase

Indexed keywords

2',3' CAMP ADENOSINE; 2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; CYCLIC AMP; UNCLASSIFIED DRUG; ADENOSINE; ADENOSINE PHOSPHATE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; KIDNEY COLLECTING TUBULE; KIDNEY METABOLISM; KIDNEY PROXIMAL TUBULE; MESANGIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; THICK ASCENDING LIMB; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; 2′,3′-CYCLIC ADENOSINE MONOPHOSPHATE; 2′,3′-CYCLIC NUCLEOTIDE 3′-PHOSPHODIESTERASE; 2′-ADENOSINE MONOPHOSPHATE; 3′-ADENOSINE MONOPHOSPHATE; ANIMAL; CELL CULTURE; HUMAN; KIDNEY; METABOLISM; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

2′,3′-CYCLIC ADENOSINE MONOPHOSPHATE; 2′,3′-CYCLIC NUCLEOTIDE 3′-PHOSPHODIESTERASE; 2′-ADENOSINE MONOPHOSPHATE; 3′-ADENOSINE MONOPHOSPHATE; ADENOSINE; CNPASE;

2',3'-CYCLIC NUCLEOTIDE 3'-PHOSPHODIESTERASE; ADENOSINE; ADENOSINE MONOPHOSPHATE; ANIMALS; CELLS, CULTURED; CYCLIC AMP; HUMANS; KIDNEY; MICE; MUSCLE, SMOOTH, VASCULAR; RATS; SIGNAL TRANSDUCTION;

EID: 84903605216     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00134.2014     Document Type: Article

References (57)

1. Arnoys EJ, Wang JL. Dual localization: proteins in extracellular and intracellular compartments. Acta Histochem 109: 89-110, 2007.
2. 2+-dependent permeability transition regulation in rat brain mitochondria by 2′,3′-cyclic nucleotides and 2′,3′-cyclic nucleotide 3′-phosphodiesterase. Am J Physiol Cell Physiol 296: C1428-C1439, 2009.
3. Bauerle JD, Grenz A, Kim JH, Lee HT, Eltzschig HK. Adenosine generation and signaling during acute kidney injury. J Am Soc Nephrol 22: 14-20, 2011.
4. Darlot F, Artuso A, Lautredou-Audouy N, Casellas D. Topology of Schwann cells and sympathetic innervation along preglomerular vessels: a confocal microscopic study in protein S100B/EGFP transgenic mice. Am J Physiol Renal Physiol 295: F1142-F1148, 2008.
5. Day YJ, Huang L, Ye H, Linden J, Okusa MD. Renal ischemiareperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages. Am J Physiol Renal Physiol 288: F722-F731, 2005.
6. Devalaraja-Narashimha K, Diener AM, Padanilam BJ. Cyclophilin D gene ablation protects mice from ischemic renal injury. Am J Physiol Renal Physiol 297: F749-F759, 2009.
7. Eirin A, Li Z, Zhang X, Krier JD, Woollard JR, Zhu XY, Tang H, Herrmann SM, Lerman A, Textor SC, Lerman LO. A mitochondrial permeability transition pore inhibitor improves renal outcomes after revascularization in experimental atherosclerotic renal artery stenosis. Hypertension 60: 1242-1249, 2012.
8. Eltzschig HK. Adenosine: an old drug newly discovered. Anesthesiology 111: 904-915, 2009.
9. Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med 364: 656-665, 2011.
10. Eltzschig HK, Kohler D, Eckle T, Kong T, Robson SC, Colgan SP. Central role of Sp1-regulated CD39 in hypoxia/ischemia protection. Blood 113: 224-232, 2009.
11. Eltzschig HK, Weissmuller T, Mager A, Eckle T. Nucleotide metabolism and cell-cell interactions. Methods Mol Biol 341: 73-87, 2006.
12. Feng L, Sun X, Csizmadia E, Han L, Bian S, Murakami T, Wang X, Robson SC, Wu Y. Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate. Neoplasia 13: 206-216, 2011.
13. Fruhbeis C, Frohlich D, Kuo WP, Amphornrat J, Thilemann S, Saab AS, Kirchhoff F, Mobius W, Goebbels S, Nave KA, Schneider A, Simons M, Klugmann M, Trotter J, Kramer-Albers EM. Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication. PLoS Biol 11: 9, 2013.
14. Frye CA, Patrick CW Jr. Isolation and culture of rat microvascular endothelial cells. In Vitro Cell Dev Biol Anim 38: 208-212, 2002.
15. Grenz A, Bauerle JD, Dalton JH, Ridyard D, Badulak A, Tak E, McNamee EN, Clambey E, Moldovan R, Reyes G, Klawitter J, Ambler K, Magee K, Christians U, Brodsky KS, Ravid K, Choi DS, Wen J, Lukashev D, Blackburn MR, Osswald H, Coe IR, Nürnberg B, Haase VH, Xia Y, Sitkovsky M, Eltzschig HK. Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice. J Clin Invest 122: 693-710, 2012.
16. Grenz A, Osswald H, Eckle T, Yang D, Zhang H, Tran ZV, Klingel K, Ravid K, Eltzschig HK. The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS Med 5: e137, 2008.
17. Hansen PB, Castrop H, Briggs J, Schnermann J. Adenosine induces vasoconstriction through Gi-dependent activation of phospholipase C in isolated perfused afferent arterioles of mice. J Am Soc Nephrol 14: 2457-2465, 2003.
18. Hansen PB, Schnermann J. Vasoconstrictor and vasodilator effects of adenosine in the kidney. Am J Physiol Renal Physiol 285: F590-F599, 2003.
19. Hinman JD, Chen CD, Oh SY, Hollander W, Abraham CR. Agedependent accumulation of ubiquitinated 2′,3′-cyclic nucleotide 3′-phosphodiesterase in myelin lipid rafts. Glia 56: 118-133, 2008.
20. Inoue T, Mi Z, Gillespie DG, Jackson EK. Cyclooxygenase inhibition reveals synergistic action of vasoconstrictors on mesangial cell growth. Eur J Pharmacol 361: 285-291, 1998.
21. Jackson EK, Gillespie DG. Extracellular 2′,3′-cAMP and 3′,5′-cAMP stimulate proliferation of preglomerular vascular endothelial cells and renal epithelial cells. Am J Physiol Renal Physiol 303: F954-F962, 2012.
22. Jackson EK, Gillespie DG, Dubey RK. 2′-AMP and 3′-AMP inhibit proliferation of preglomerular vascular smooth muscle cells and glomerular mesangial cells via A2B receptors. J Pharmacol Exp Ther 337: 444-450, 2011.
23. Jackson EK, Mi Z. Regulation of renovascular adenosine 3′,5′-cyclic monophosphate in spontaneously hypertensive rats. Hypertension 54: 270-277, 2009.
24. Jackson EK, Mi Z, Zhu C, Dubey RK. Adenosine biosynthesis in the collecting duct. J Pharmacol Exp Ther 307: 888-896, 2003.
25. Jackson EK, Ren J, Cheng D, Mi Z. Extracellular cAMP-adenosine pathways in the mouse kidney. Am J Physiol Renal Physiol 301: F565-F573, 2011.
26. Jackson EK, Ren J, Gillespie DG, Dubey RK. Extracellular 2′,3′-cyclic adenosine 5′-monophosphate is a potent inhibitor of preglomerular vascular smooth muscle cell and mesangial cell growth. Hypertension 56: 151-158, 2010.
27. Jackson EK, Ren J, Mi Z. Extracellular 2′,3′-cAMP is a source of adenosine. J Biol Chem 284: 33097-33106, 2009.
28. Jackson EK, Zacharia LC, Zhang M, Gillespie DG, Zhu C, Dubey RK. cAMP-adenosine pathway in the proximal tubule. J Pharmacol Exp Ther 317: 1219-1229, 2006.
29. Kim M, Chen SWC, Park SW, Kim M, D'Agati VD, Yang J, Lee HT. Kidney-specific reconstitution of the A1 adenosine receptor in A1 adenosine receptor knockout mice reduces renal ischemia-reperfusion injury. Kidney Int 75: 809-823, 2009.
30. Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev 87: 99-163, 2007.
31. Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, Braun PE, Griffiths IR, Nave KA. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 33: 366-374, 2003.
32. 2a adenosine receptors. Am J Physiol Renal Physiol 282: F844-F852, 2002.
33. 3 receptors. Am J Physiol Renal Physiol 278: F380-F387, 2000.
34. Lee HT, Kim M, Jan M, Penn RB, Emala CW. Renal tubule necrosis and apoptosis modulation by A1 adenosine receptor expression. Kidney Int 71: 1249-1261, 2007.
35. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2[-{increment}{increment}CT] method. Methods 25: 402-408, 2001.
36. Mokkapatti R, Vyas SJ, Romero GG, Mi Z, Inoue T, Dubey RK, Gillespie DG, Stout AK, Jackson EK. Modulation by angiotensin II of isoproterenol-induced cAMP production in preglomerular microvascular smooth muscle cells from normotensive and genetically hypertensive rats. J Pharmacol Exp Ther 287: 223-231, 1998.
37. Muthuraman A, Sood S, Singla SK, Rana A, Singh A, Singh A, Singh J. Ameliorative effect of flunarizine in cisplatin-induced acute renal failure via mitochondrial permeability transition pore inactivation in rats. Naunyn Schmiedebergs Arch Pharmacol 383: 57-64, 2011.
38. Ohta M, Toyama K, Gutterman DD, Campbell WB, Lemaitre V, Teraoka R, Miura H. Ecto-5′-nucleotidase, CD73, is an endotheliumderived hyperpolarizing factor synthase. Arterioscler Thromb Vasc Biol 33: 629-636, 2013.
39. Okusa MD. A2A adenosine receptor: a novel therapeutic target in renal disease. Am J Physiol Renal Physiol 282: F10-F18, 2002.
40. Okusa MD, Linden J, Huang L, Rieger JM, Macdonald TL, Huynh LP. A2A adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion. Am J Physiol Renal Physiol 279: F809-F818, 2000.
41. Okusa MD, Linden J, Huang L, Rosin DL, Smith DF, Sullivan G. Enhanced protection from renal ischemia-reperfusion injury with A2Aadenosine receptor activation and PDE 4 inhibition. Kidney Int 59: 2114-2125, 2001.
42. Okusa MD, Linden J, Macdonald T, Huang L. Selective A2A adenosine receptor activation reduces ischemia-reperfusion injury in rat kidney. Am J Physiol Renal Physiol 277: F404-F412, 1999.
43. Oppermann M, Hansen PB, Castrop H, Schnermann J. Vasodilatation of afferent arterioles and paradoxical increase of renal vascular resistance by furosemide in mice. Am J Physiol Renal Physiol 293: F279-F287, 2007.
44. Poth JM, Brodsky K, Ehrentraut H, Grenz A, Eltzschig HK. Transcriptional control of adenosine signaling by hypoxia-inducible transcription factors during ischemic or inflammatory disease. J Mol Med 91: 183-193, 2013.
45. Ren J, Mi Z, Stewart NA, Jackson EK. Identification and quantification of 2′,3′-cAMP release by the kidney. J Pharmacol Exp Ther 328: 855-865, 2009.
46. Riera M, Torras J, Cruzado JM, Lloberas N, Liron J, Herrero I, Navarro MA, Grinyo JM. The enhancement of endogenous cAMP with pituitary adenylate cyclase-activating polypeptide protects rat kidney against ischemia through the modulation of inflammatory response. Transplantation 72: 1217-1223, 2001.
47. Saotome M, Katoh H, Yaguchi Y, Tanaka T, Urushida T, Satoh H, Hayashi H. Transient opening of mitochondrial permeability transition pore by reactive oxygen species protects myocardium from ischemiareperfusion injury. Am J Physiol Heart Circ Physiol 296: H1125-H1132, 2009.
48. Schmidt S. Candidate autoantigens in multiple sclerosis. Mult Scler 5: 147-160, 1999.
49. Sprinkle TJ. 2′,3′-Cyclic nucleotide 3′-phosphodiesterase, an oligodendrocyte-Schwann cell and myelin-associated enzyme of the nervous system. Crit Rev Neurobiol 4: 235-301, 1989.
50. Thompson RJ. 2′,3′-Cyclic nucleotide-3′-phosphohydrolase and signal transduction in central nervous system myelin. Biochem Soc Trans 20: 621-626, 1992.
51. Verrier JD, Jackson TC, Bansal R, Kochanek PM, Puccio AM, Okonkwo DO, Jackson EK. The brain in vivo expresses the 2′,3′-cAMPadenosine pathway. J Neurochem 122: 115-125, 2012.
52. Verweij M, Sluiter W, van den Engel S, Jansen E, Ijzermans JNM, de Bruin RWF. Altered mitochondrial functioning induced by preoperative fasting may underlie protection against renal ischemia/reperfusion injury. J Cell Biochem 114: 230-237, 2013.
53. Visovatti SH, Hyman MC, Bouis D, Neubig R, McLaughlin VV, Pinsky DJ. Increased CD39 nucleotidase activity on microparticles from patients with idiopathic pulmonary arterial hypertension. PLos One 7: e40829, 2012.
54. Vogel US, Thompson RJ. Molecular structure, localization, and possible functions of the myelin-associated enzyme 2′,3′-cyclic nucleotide 3′-phosphodiesterase. J Neurochem 50: 1667-1677, 1988.
55. Wen J, Grenz A, Zhang Y, Dai Y, Kellems RE, Blackburn MR, Eltzschig HK, Xia Y. A2B adenosine receptor contributes to penile erection via PI3K/AKT signaling cascade-mediated eNOS activation. FASEB J 25: 2823-2830, 2011.
56. Yuan X, Chittajallu R, Belachew S, Anderson S, McBain CJ, Gallo V. Expression of the green fluorescent protein in the oligodendrocyte lineage: a transgenic mouse for developmental and physiological studies. J Neurosci Res 70: 529-545, 2002.
57. Zhang W, Zhang Y, Wang W, Dai Y, Ning C, Luo R, Sun K, Glover L, Grenz A, Sun H, Tao L, Zhang W, Colgan SP, Blackburn MR, Eltzschig HK, Kellems RE, Xia Y. Elevated ecto-5′-nucleotidase-mediated increased renal adenosine signaling via A2B adenosine receptor contributes to chronic hypertension. Circ Res 112: 1466-1478, 2013.